IMR Press / EJGO / Volume 41 / Issue 3 / DOI: 10.31083/j.ejgo.2020.03.5098
Open Access Case Report
Postmenopausal recurrent retrovaginal extramural gastrointestinal stromal tumor: a case report
Show Less
1 People’s Hospital of Fu Yang No. 63, luci street, yingzhou district, fuyang city, 236000 An Hui, China
Eur. J. Gynaecol. Oncol. 2020 , 41(3), 473–476; https://doi.org/10.31083/j.ejgo.2020.03.5098
Submitted: 9 December 2018 | Accepted: 25 January 2019 | Published: 15 June 2020
Abstract

Mesenchymal tumors are divided into gastrointestinal stromal tumors (GIST) and extra-intestinal tumors (EGIST). They can occur in various parts of the abdominal cavity, including the greater omentum, rectovaginal septum, peritoneum, retroperitoneum and extremely rarely, in the vagina. Vaginal cancer is an uncommon gynecological tumor and recurrent posterior vaginal gastrointestinal stromal tumors are even rarer. Currently, surgical resection is the main treatment method for this disease. With the deepening molecular understanding of gastrointestinal stromal tumors, in particular the role of c-KIT mutations, targeted therapy with Imatinib has been used in the adjuvant setting, achieving good results. We report a recent case of postmenopausal recurrent retrovaginal gastrointestinal stromal tumor, treated at Linquan County Hospital.

Keywords
Vagina
Gastrointestinal stromal tumor
Menopause
Imatinib
Share
Back to top